Previous 10 | Next 10 |
The European Commission ((EC)) has approved Merck's (MRK) Keytruda in combination with platinum- and fluoropyrimidine-based chemotherapy for the first-line treatment of patients with esophageal cancer or HER2-negative gastroesophageal junction ((GEJ)) adenocarcinoma in adults whose tumors exp...
CR's quarterly revenue rose 4% Y/Y. Aerospace revenue fell, but it may have reached a trough in Q4 2020. EBITDA grew 35% as the company experienced efficiencies in SG&A costs. Payment & Processing could be spurred by the gaming industry. Aerospace could rebound on global p...
Compugen (CGEN) presents updated data from its Phase 1 study of COM701 as a monotherapy, and in combination study with Opdivo (nivolumab) at the ASCO 2021 Annual Meeting. Data highlights are with a cut-off of April 15 2021.COM701 and Opdivo combination: In 15 evaluable patients, COM701 i...
Precision BioSciences (DTIL) announces progress on two strategies designed to optimize the durability of allogeneic CAR T therapy in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma ((NHL)).The Company reported updated interim results from its Phase 1/2a study of PBCAR0191, an inv...
Circor (CIR) rose just over 1.1% after some speculation that Crane Co. (CR) could potentially show renewed interest in the company.Crane's announcement today that it's selling its engineered materials segment to Grupo Verzatec for $360M may be a sign that the company could look to d...
Crane (CR) agrees to sell its Engineered Materials segment to Grupo Verzatec S.A. de C.V. for $360M, and says its Fluid Handling segment has been renamed Process Flow Technologies.Citing the continued strength across its businesses, Crane says it is maintaining guidance for full-year adjusted...
Some people say that #timing does not matter, but it does. If you were to #buyandhold Crane (NYSE: CR) at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling. Over time, Stock Traders Daily has found a way to les...
The industrial sector is now leading the U.S. economy’s resurgence after being severely impacted last year. President Biden’s proposed $2 trillion-plus infrastructure spending bill should further boost the sector’s growth. With this in mind, we think it could be wise to b...
#Investors in Crane (NYSE: CR) like to make good #decisions, that means they like to #buyandsell at the right times, and to do that the best tools involve charts, pivot points, and the technical data. Below, we have provided a snapshot for CR that reveals this informa...
Crane Co (CR) Q1 2021 Earnings Conference Call May 04, 2021, 10:00 ET Company Participants Jason Feldman - VP, IR Max Mitchell - President, CEO & Director Richard Maue - SVP & CFO Conference Call Participants Matt Summerville - D.A. Davidson & Co. Adam Farley - Stifel, Nicolaus &a...
News, Short Squeeze, Breakout and More Instantly...
Crane Company (NYSE: CR) today announced its regular quarterly dividend of $0.205 per share for the third quarter of 2024. The dividend is payable on September 11, 2024 to shareholders of record as of August 30, 2024. About Crane Company Crane Company has delivered innovation and tech...
Shares of Crane Co. (NYSE: CR) traded at a new 52-week high today and are currently trading at $155.82. So far today, approximately 32,113 shares have been exchanged, as compared to an average 30-day volume of 247.44k shares. Crane Company, together with its subsidiaries, manufactures and sel...
Crane Company (NYSE: CR) announces the following schedule and teleconference information for its second quarter 2024 earnings release: Earnings Release: July 29, 2024 after close of market by public distribution and the Crane Company website at www.craneco.com . Teleconference...